Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q2 FY27

Shree Ganesh Bio-Tech (India) Q2 FY27 Results: Net Loss of ₹0.1 Cr

Shree Ganesh Biotech approved unaudited results for the half year ended September 2026. Half-year performance shows a net loss compared with last year's profit.

Q2 FY27 at a glance · ₹ crore
MetricQ2 FY27Q1 FY27Q2 FY26
Revenue from operations0.21.40.8
Other income0.30.30.4
Total income0.51.81.2
Profit before exceptional items & tax-0.1-0.60.0
Profit before tax-0.1-0.60.0
Net profit-0.1-0.60.0
Operating margin-20.0%-33.3%0.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Revenue, year on year-75.00%
Operating profit, quarter on quarter+55.60%
Source

BSE results filing, NSE: SHREEGANES. Figures extracted from the filing.

Read the filing ↗

Shree Ganesh Bio-Tech (India) Ltd: key numbers

Share price
₹0.45
Market cap
₹17.94 Cr
Revenue (annual)
₹4.97 Cr
Net profit (annual)
₹0.38 Cr
P/E (TTM)
-46.4×Sector 45.9×
Promoter holding
0.00%+0.00% QoQ
FII holding
1.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shree Ganesh Bio-Tech (India) Ltd

All →